Ferring Makes Important Milestone For Microbiome With Rebyota Approval

 
• By Alaric DeArment

The microbiome therapy won approval for preventing recurrence of Clostridioides difficile infections, but an analyst said the future could be in more targeted approaches.

The FDA approved Ferring's microbiome drug, Rebyota, for preventing recurrence of C. difficile infections • Source: Shutterstock

More from New Products

More from Scrip